Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1020 publications
Disparities in the access to and use of biologic and targeted synthetic treatments in patients with inflammatory rheumatic and musculoskeletal diseases: a scoping review.
Journal: EULAR rheumatology open
Published: August 01, 2026
Facilitating Communication for Family Members of Critically Ill Patients During and Following a Hospital Stay: A Randomized Controlled Trial.
Journal: Critical care medicine
Published: July 22, 2026
Cross-cohort analysis of expression and splicing quantitative trait loci in TOPMed.
Journal: Science (New York, N.Y.)
Published: July 16, 2026
Essential Informatics Tools and Computing Infrastructure for Big Data to Advance Artificial Intelligence in Rheumatology.
Journal: Rheumatic diseases clinics of North America
Published: July 06, 2026
Real-World Treatment Patterns in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Journal: ACR open rheumatology
Published: April 29, 2026
Effects of air pollution on disease activity in patients with rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: April 12, 2026
Osteoporosis treatment adherence trajectories, comedication patterns, and romosozumab persistence among early users: A data-driven analysis.
Journal: Bone
Published: April 09, 2026
Use of Semaglutide and Tirzepatide in Rheumatic and Musculoskeletal Diseases: Insights on Initiation Patterns and Weight Loss From the Rheumatology Informatics System for Effectiveness Registry.
Journal: ACR open rheumatology
Published: April 06, 2026
Response to Correspondence on 'Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial'.
Journal: Annals of the rheumatic diseases
Published: March 24, 2026
Certolizumab Inhibits Radiographic Progression in Patients with Early Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Pooled, Post‑Hoc Analysis of the Phase 3 C‑EARLY and C‑OPERA Trials.
Journal: Joint bone spine
Published: February 24, 2026
Certolizumab inhibits radiographic progression in patients with early rheumatoid arthritis and high rheumatoid factor levels: A pooled, post-hoc analysis of the phase 3 C-EARLY and C-OPERA trials.
Journal: Joint bone spine
Published: February 24, 2026
Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica.
Journal: RMD open
Published: February 16, 2026
Last Updated: 09/26/2026